A Clinical Trial Comparing Glycaemic Control and Safety of Insulin Degludec/Liraglutide (IDegLira) Versus Insulin Glargine (IGlar) as add-on Therapy to SGLT2i in Subjects With Type 2 Diabetes Mellitus

Completed · Phase 3

Conditions studied: Diabetes, Diabetes Mellitus, Type 2

In brief

This trial is conducted globally. The aim of this trial is comparing glycaemic control and safety of insulin degludec/liraglutide (IDegLira) versus insulin glargine (IGlar) as add-on therapy to SGLT2i (sodium-glucose cotransporter 2 inhibitors) in subjects with type 2 diabetes mellitus.

Key facts

Study ID

NCT02773368

Run by

Novo Nordisk A/S

People needed

420

Starts

2016-05-23

Expected to finish

2017-10-23

Last updated by the study team

2020-08-11

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Novo Nordisk Investigational Site — La Jolla, California, United States
• Novo Nordisk Investigational Site — Mission Viejo, California, United States
• Novo Nordisk Investigational Site — Northridge, California, United States
• Novo Nordisk Investigational Site — Palm Springs, California, United States
• Novo Nordisk Investigational Site — San Ramon, California, United States
• Novo Nordisk Investigational Site — Boynton Beach, Florida, United States
• Novo Nordisk Investigational Site — Chiefland, Florida, United States
• Novo Nordisk Investigational Site — Skokie, Illinois, United States
• Novo Nordisk Investigational Site — Avon, Indiana, United States
• Novo Nordisk Investigational Site — Rockville, Maryland, United States
• Novo Nordisk Investigational Site — Las Vegas, Nevada, United States
• Novo Nordisk Investigational Site — Teaneck, New Jersey, United States
• Novo Nordisk Investigational Site — Albany, New York, United States
• Novo Nordisk Investigational Site — West Seneca, New York, United States
• Novo Nordisk Investigational Site — Whiteville, North Carolina, United States
• Novo Nordisk Investigational Site — Mason, Ohio, United States
• Novo Nordisk Investigational Site — Greer, South Carolina, United States
• Novo Nordisk Investigational Site — Bristol, Tennessee, United States
• Novo Nordisk Investigational Site — Austin, Texas, United States
• Novo Nordisk Investigational Site — Houston, Texas, United States
• Novo Nordisk Investigational Site — Longview, Texas, United States
• Novo Nordisk Investigational Site — San Antonio, Texas, United States
• Novo Nordisk Investigational Site — Kenosha, Wisconsin, United States
• Novo Nordisk Investigational Site — Buenos Aires, Argentina
• Novo Nordisk Investigational Site — Glendale, Arizona, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.